Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Factors affecting early morbidity and mortality in non-small cell lung cancer surgery, the experience of Surgical Clinic No. 1, Tg. Mureş.

Suciu B, Bud V, Copotoiu C, Brânzaniuc K, Copotoiu R, Fodor D, Butiurca V.

Rev Med Chir Soc Med Nat Iasi. 2011 Jan-Mar;115(1):116-26.

PMID:
21682188
2.

Final results after pneumonectomy for non-small cell lung cancer.

Dalton ML, Clericuzio CP.

Curr Surg. 2005 Sep-Oct;62(5):509-11. No abstract available.

PMID:
16125608
3.

Morbidity and mortality after induction chemotherapy followed by surgery in IIIa-N2 non small cell lung cancer.

Borreman P, De Leyn P, Decaluwé H, Moons J, Van Raemdonck D, Nafteux P, Coosemans W, Lerut T.

Acta Chir Belg. 2009 May-Jun;109(3):333-9.

PMID:
19943589
4.

[Thoracoscopic surgery for elderly patients].

Okada Y, Kondo T.

Kyobu Geka. 2005 Jul;58(8 Suppl):751-5. Japanese.

PMID:
16097631
5.

Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.

Yildizeli B, Dartevelle PG, Fadel E, Mussot S, Chapelier A.

Ann Thorac Surg. 2008 Oct;86(4):1065-75; discussion 1074-5. doi: 10.1016/j.athoracsur.2008.07.004.

PMID:
18805134
6.

Do women live longer following lung resection for carcinoma?

Alexiou C, Onyeaka CV, Beggs D, Akar R, Beggs L, Salama FD, Duffy JP, Morgan WE.

Eur J Cardiothorac Surg. 2002 Feb;21(2):319-25.

PMID:
11825743
7.

Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years.

Pasini F, Verlato G, Durante E, de Manzoni G, Valduga F, Accordini S, Pedrazzani C, Terzi A, Pelosi G.

Br J Cancer. 2003 Jun 2;88(11):1666-8.

8.

Long-term survival after video-assisted thoracic surgery lobectomy for primary lung cancer.

Yamamoto K, Ohsumi A, Kojima F, Imanishi N, Matsuoka K, Ueda M, Miyamoto Y.

Ann Thorac Surg. 2010 Feb;89(2):353-9. doi: 10.1016/j.athoracsur.2009.10.034.

PMID:
20103297
9.

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.

Weder W, Collaud S, Eberhardt WE, Hillinger S, Welter S, Stahel R, Stamatis G.

J Thorac Cardiovasc Surg. 2010 Jun;139(6):1424-30. doi: 10.1016/j.jtcvs.2010.02.039. Epub 2010 Apr 24.

10.

eComment: Mortality, morbidity and late survival in lung resection for non-small cell lung cancer in the elderly population.

Cafarotti S, Leuzzi G, Lococo F, Congedo MT.

Interact Cardiovasc Thorac Surg. 2011 May;12(5):753. doi: 10.1510/icvts.2010.259002A. No abstract available.

PMID:
21555441
11.

Postoperative mortality in lung cancer patients.

Nagai K, Yoshida J, Nishimura M.

Ann Thorac Cardiovasc Surg. 2007 Dec;13(6):373-7. Review.

PMID:
18292718
12.

[Non-small cell lung cancer: surgical trends as a function of age].

Riquet M, Medioni J, Manac'h D, Dujon A, Souilamas R, Le Pimpec Barthes F, Hubsch JP.

Rev Mal Respir. 2001 Apr;18(2):173-84. French.

PMID:
11424713
13.

Survival and risk factors of surgically treated mediastinal invasion T4 non-small cell lung cancer.

Yang HX, Hou X, Lin P, Rong TH, Yang H, Fu JH.

Ann Thorac Surg. 2009 Aug;88(2):372-8. doi: 10.1016/j.athoracsur.2009.04.018.

PMID:
19632375
14.

[Surgery for non-small cell lung cancer].

Dahle G, Brøyn T, Stavem K.

Tidsskr Nor Laegeforen. 2003 May 29;123(11):1525-6. Norwegian.

15.

Pulmonary resection of non-small cell lung cancer: is survival in the elderly not affected by tumor stage after complete resection?

Bölükbas S, Beqiri S, Bergmann T, Trainer S, Fisseler-Eckhoff A, Schirren J.

Thorac Cardiovasc Surg. 2008 Dec;56(8):476-81. doi: 10.1055/s-2008-1038963. Epub 2008 Nov 14.

PMID:
19012213
16.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non-small cell lung cancer.

Kim HK, Choi YS, Kim J, Shim YM, Kim K.

J Thorac Cardiovasc Surg. 2010 Dec;140(6):1288-93. doi: 10.1016/j.jtcvs.2010.06.011. Epub 2010 Jul 14.

17.

Long-term results of sleeve lobectomy in the management of non-small cell lung carcinoma and low-grade neoplasms.

Merritt RE, Mathisen DJ, Wain JC, Gaissert HA, Donahue D, Lanuti M, Allan JS, Morse CR, Wright CD.

Ann Thorac Surg. 2009 Nov;88(5):1574-81; discussion 1581-2. doi: 10.1016/j.athoracsur.2009.07.060.

PMID:
19853115
18.

Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).

Tanaka F, Miyahara R, Ohtake Y, Yanagihara K, Fukuse T, Hitomi S, Wada H.

Eur J Cardiothorac Surg. 1998 Sep;14(3):256-62; discussion 263-4.

PMID:
9761434
19.

[Prognostic factor analysis of pneumonectomy for non-small cell lung cancer].

Wang X, Ma G, Rong T, Huang Z, Yang M, Zeng C, Lin P, Long H, Fu J, Wang S, Yang X.

Zhonghua Wai Ke Za Zhi. 2002 Aug;40(8):567-70. Chinese.

PMID:
12417065
20.

Supplemental Content

Support Center